TickerFacts.

Supernus Pharmaceuticals, Inc. (SUPN): Gross Profit

Revenue minus cost of revenue for the same annual period and currency, computed by TickerFacts from the filed figures. The issuer may report gross profit or margin on a different basis.

Computed by TickerFacts from revenue minus cost of revenue. This may differ from the issuer's reported gross profit or margin; check the revenue and cost definitions.

$644.39M
Year ended 2025-12-31
$731.41M
Trailing 12 months to 2026-06-30
+3.6%
3-year compound annual growth
+6.6%
5-year compound annual growth
+16.6%
10-year compound annual growth
2013-12-31: $10.91M2014-12-31: $86.92M2015-12-31: $139.04M2016-12-31: $203.02M2017-12-31: $287.02M2020-12-31: $467.94M2022-12-31: $580.02M2023-12-31: $523.74M2024-12-31: $583.91M2025-12-31: $644.39M$644.39M
2013-12-31 Gross Profit (USD) 2025-12-31
Period endedGross ProfitChange YoYSource filing
2025-12-31$644.39M+10.4%2026-03-02, From 2025-01-01
2024-12-31$583.91M+11.5%2026-03-02, From 2024-01-01
2023-12-31$523.74M-9.7%2026-03-02, From 2023-01-01
2022-12-31$580.02Mn/a2025-02-25, From 2022-01-01
No annual figure between 2020-12-31 and 2022-12-31.
2020-12-31$467.94Mn/a2023-03-09, From 2020-01-01
No annual figure between 2017-12-31 and 2020-12-31.
2017-12-31$287.02M+41.4%2020-02-28, From 2017-01-01
2016-12-31$203.02M+46.0%2019-03-01, From 2016-01-01
2015-12-31$139.04M+60.0%2018-03-01, From 2015-01-01
2014-12-31$86.92M+696.3%2017-03-16, From 2014-01-01
2013-12-31$10.91Mn/a2017-01-20, From 2013-01-01

Gross Profit at similar companies

Companies with the same SEC industry code (Pharmaceutical Preparations), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedGross ProfitChange YoY
Supernus Pharmaceuticals, Inc. (SUPN)2025-12-31$644.39M+10.4%
Amphastar Pharmaceuticals, Inc. (AMPH)2025-12-31$356.06M-4.8%
Pacira BioSciences, Inc. (PCRX)2025-12-31$576.66M+8.7%
Emergent BioSolutions Inc. (EBS)2025-12-31$416.70M+15.0%
Kiniksa Pharmaceuticals International, plc (KNSA)2025-12-31$599.89M+65.6%
Collegium Pharmaceutical, Inc (COLL)2025-12-31$463.26M+22.8%
TG Therapeutics, Inc. (TGTX)2025-12-31$515.57M+77.5%
Opko Health, Inc. (OPK)2025-12-31$205.94M-5.8%
Insmed Inc (INSM)2025-12-31$483.49M+73.9%

Compare SUPN, AMPH, PCRX, EBS side by side · Screen every company in Pharmaceutical Preparations ↗